Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist

OBJECTIVES: Obesity is a complex disease associated with a high risk of comorbidities. Gastric bypass surgery, an invasive procedure with low patient eligibility, is currently the most effective intervention that achieves sustained weight loss. This beneficial effect is attributed to alterations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Grunddal, Kaare V., Diep, Thi A., Petersen, Natalia, Tough, Iain R., Skov, Louise J., Liu, Lingzhi, Buijink, Jesse A., Mende, Franziska, Jin, Chunyu, Jepsen, Sara L., Sørensen, Louis M.E., Achiam, Michael P., Strandby, Rune B., Bach, Anders, Hartmann, Bolette, Frimurer, Thomas M., Hjorth, Siv A., Bouvier, Michel, Cox, Helen, Holst, Birgitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042403/
https://www.ncbi.nlm.nih.gov/pubmed/33711555
http://dx.doi.org/10.1016/j.molmet.2021.101207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042403/
https://www.ncbi.nlm.nih.gov/pubmed/33711555
http://dx.doi.org/10.1016/j.molmet.2021.101207

Ejemplares similares